| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/1991 | WO1991005551A1 Antihypertensive compositions and use thereof |
| 04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 04/18/1991 | WO1991005038A1 Blood-brain barrier model |
| 04/18/1991 | WO1991004985A1 Dehydrodidemnin b |
| 04/18/1991 | WO1991004977A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof |
| 04/18/1991 | WO1991004972A1 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents |
| 04/18/1991 | WO1991004754A2 Illudin analogs as anti-tumor agents |
| 04/18/1991 | WO1991004741A1 Composition for the treatment of progressive myopia |
| 04/18/1991 | WO1991004740A1 Combined preparation with anti-thrombotic action |
| 04/18/1991 | WO1991004739A1 Use of prostacyclin derivatives against metastases |
| 04/18/1991 | WO1991004735A1 Compositions and methods for weight reduction |
| 04/18/1991 | WO1991004734A1 Pharmaceutical compositions containing 4,6-tioxoheptanoic acid or its derivatives |
| 04/18/1991 | WO1991004727A1 Device for oral administration of an active principle for preventive treatment of caries in babies |
| 04/18/1991 | WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/18/1991 | WO1991004663A1 6-amino-1,2-benzopyrones useful for treatment of viral diseases |
| 04/18/1991 | DE3934405A1 Verwendung von antigestagenen zur herstellung von arzneimitteln Use of antigestagens for the preparation of medicaments |
| 04/18/1991 | DE3933780A1 Use of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzo-thiazole or 2-ami - or 2-amino-6-allyl-5,6-7,8-tetra:hydro-4h-thiazolo (4,5-d) azepine |
| 04/18/1991 | CA2067803A1 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof |
| 04/18/1991 | CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/18/1991 | CA2027792A1 Water and solvent soluble axial hydroxy and mono- and di-carboxylic acid derivatives having high tumor activity |
| 04/18/1991 | CA2027738A1 5-{2-[(2-amino-2-oxoethyl) (methyl)amino]ethyl}-2,3-dihydro-3-hydroxy-2-(4-methoxyphen yl)-1,5(5h)-benzothiazepin-4-one derivatives, their preparation and their application in therapy |
| 04/18/1991 | CA2027725A1 Use of a polypeptide with human interleukin-2 activity for preparation of pharmaceutical compositions used in leukemia treatment |
| 04/18/1991 | CA2027724A1 15-substituted 20,21-dinoreburnamenine derivatives, process for preparing the same and new intermediates thus produced, use thereof as drugs and compositions containing them |
| 04/18/1991 | CA2027715A1 3-aryloxazolidinone derivatives process for their preparation and their use in therapy |
| 04/18/1991 | CA2027702A1 Pyridone products, preparation process, new intermediates obtained, application as drugs and pharmaceutical compositions containing them |
| 04/18/1991 | CA2027624A1 S (+)-ibuprofen-l-amino acid and (+)-ibuprofen-d-amino acid as onset-hastened enhanced analgesics |
| 04/18/1991 | CA2027243A1 Intraoral formulated trifluorobenzodiazepines and the use thereof |
| 04/17/1991 | EP0423032A2 Process for the preparation of isoxazolyl and isothiazolyl imidazobenzodiazepines, new derivatives thus obtained, their use as medicaments and compositions containing them |
| 04/17/1991 | EP0423015A1 Effervescent nails composition |
| 04/17/1991 | EP0423012A2 Method of curing liver diseases by using pyrrolo quinoline quinone triesters and novel pyrrolo quinoline quinone triesters |
| 04/17/1991 | EP0423011A1 Cosmetic or pharmaceutic composition for topical application containing at least a retinoide derivative and at least a pyrimidine derivative |
| 04/17/1991 | EP0422978A1 Process for the preparation of an aqueous dispersion of lipid vesicles and composition based on the dispersion thus obtained |
| 04/17/1991 | EP0422975A1 Alpha-glucosidase inhibitors |
| 04/17/1991 | EP0422938A1 Fibrinogen receptor antagonists |
| 04/17/1991 | EP0422895A1 Chemical compounds |
| 04/17/1991 | EP0422889A2 Phenethanolamine compounds |
| 04/17/1991 | EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 04/17/1991 | EP0422846A2 Aroyl-ureas |
| 04/17/1991 | EP0422843A2 6-0 Methylerythromycin A oxime derivatives |
| 04/17/1991 | EP0422818A1 New polyether antibiotic |
| 04/17/1991 | EP0422681A1 Collagen containing ophthalmic formulation |
| 04/17/1991 | EP0422666A2 6-Substituted-1,2,3,4-tetrahydroisoquinolines |
| 04/17/1991 | EP0422638A1 Novel inosine/guanosine derivatives |
| 04/17/1991 | EP0422596A2 Tricyclic carbapenem compounds |
| 04/17/1991 | EP0422566A1 A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives |
| 04/17/1991 | EP0422497A2 Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them |
| 04/17/1991 | EP0422490A2 Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels |
| 04/17/1991 | EP0422485A2 Quinolone carboxylic acid derivatives, process for their preparation and their use |
| 04/17/1991 | EP0422450A2 Chroman derivatives |
| 04/17/1991 | EP0422329A1 Substituted dibenzofurans and methods of using same |
| 04/17/1991 | EP0422328A2 Substituted isoquinolines and their use |
| 04/17/1991 | EP0422307A1 Novel alpha-glucosidase inhibitors |
| 04/17/1991 | EP0422181A1 Method and means for inducing, resp., preventing constriction of the pupil in the eye |
| 04/17/1991 | EP0422119A1 Benzothiophene derivatives useful for modifying feeding behavior and obsessive-compulsive behavior |
| 04/17/1991 | EP0422102A1 5-OXA, 5-THIA, 5-AZA HMG-CoA REDUCTASE INHIBITORS |
| 04/17/1991 | EP0422100A1 11-g(b)-SUBSTITUTED PROGESTERONE ANALOGS. |
| 04/17/1991 | EP0422097A1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo. |
| 04/17/1991 | EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use |
| 04/17/1991 | EP0422055A1 Novel ursodeoxycholic acid derivative |
| 04/17/1991 | EP0422051A1 Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their preparation |
| 04/17/1991 | EP0421997A1 Use of a glycine b partial agonist for memory and learning enhancement or treatment of a cognitive disorder |
| 04/17/1991 | EP0416033A4 Macrocyclic chelates and methods of use thereof |
| 04/17/1991 | EP0235151B1 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections |
| 04/17/1991 | CN1050719A Epiopodophyllotoxin altroside derivatives |
| 04/17/1991 | CN1050717A Cephalosporin derivatives |
| 04/17/1991 | CN1050715A Quinoline derivatives, their production and use |
| 04/17/1991 | CN1012365B Prepn. of 2-(n-subst-guanidyl)-4-heteroaryl thiazole antiulcer agent |
| 04/16/1991 | US5008452 Aminoethyl oximes |
| 04/16/1991 | US5008441 Contacting caffeic acid and phenylethyl alcohol; anti-inflammatory and anticarcinogenic agents |
| 04/16/1991 | US5008400 Bicyclic aminoacids as intermediates |
| 04/16/1991 | US5008399 Diastereoselective preparation of phosphinate esters |
| 04/16/1991 | US5008384 Process for the production of O.sup. 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine |
| 04/16/1991 | US5008295 Orally administering or injecting anticarcinogenic agent alpha-carotine |
| 04/16/1991 | US5008294 Topical administration |
| 04/16/1991 | US5008293 Process for the treatment of the skin to alleviate skin diseases arising from contact sensitization or irritation utilizing p-substituted phenoxy alkanols |
| 04/16/1991 | US5008292 Pesticidal method |
| 04/16/1991 | US5008291 Dietary supplement containing calcium glucarate and n-(4-hydroxyphenyl)retinamide; treating mammary cancer |
| 04/16/1991 | US5008290 Sulphonamidoethyl compounds and pharmaceutical compositions comprising these compounds |
| 04/16/1991 | US5008289 Composition for treating nasal disorders and headaches |
| 04/16/1991 | US5008287 Pharmaceutical compositions having antineoplastic activity |
| 04/16/1991 | US5008284 Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
| 04/16/1991 | US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 04/16/1991 | US5008280 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them |
| 04/16/1991 | US5008279 Inotropic, antihypertensive agents |
| 04/16/1991 | US5008278 Therapeutically active compound and a process for its preparation |
| 04/16/1991 | US5008274 Carbostyril derivatives and salts thereof and pharmaceutical composition for inhibiting adhesion of thrombocytes |
| 04/16/1991 | US5008273 Amino acid derivatives and their pharmaceutical use |
| 04/16/1991 | US5008272 Antagonists; useful in treatment of psychotic disorders, central nervous system disorder; antidepressant |
| 04/16/1991 | US5008269 Administering Resonium A ion exchange resin |
| 04/16/1991 | US5008268 2-aminopyrimidinone derivatives |
| 04/16/1991 | US5008266 4(3H)-quinazolinone derivatives and pharmaceutical compositions |
| 04/16/1991 | US5008263 Diazepine antiallergy agents |
| 04/16/1991 | US5008262 Method of treating trichotillomania and onchyphagia |
| 04/16/1991 | US5008259 Antibiotics active against strains of Pseudomonas and stable to beta-lactamase |
| 04/16/1991 | US5008258 Cephalosporin derivatives |
| 04/16/1991 | US5008256 Gastrointestinal disorders |
| 04/16/1991 | US5008255 Method for enhancing solubility of trimethoprim with sodium sulfacetamide, and synergistic pharmaceutical compositions derived therefrom |
| 04/16/1991 | US5008253 Sulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological properties |
| 04/16/1991 | US5008252 Process for inhibiting herpes simplex virus-specified thymidine kinase |
| 04/16/1991 | US5008250 Parasiticides |